Introduction
Natural killer T (NKT) cells are unconventional, glycolipidreactive, and semi-invariant T cells that are restricted to the antigen-presenting molecule CD1d and appear to bridge innate and adaptive immunity (1) (2) (3) . Importantly, CD1d is mainly expressed on dendritic cells (DCs), macrophages, and B cells, implying that NKT cells primarily interact with antigen-presenting cells (APCs) rather than tissue cells (4) .
As with conventional T cells, CD4 and CD8 molecules have been used to map the developmental pathway of NKT cells, but the pattern of these markers for NKT cells is more difficult to determine during development. CD1d-tetramer restricted NKT cells are generally CD4 -CD8 -double negative or CD4 + cells in mice and humans. However, CD8 + NKT cells usually are present in humans in cases of infection and carcinoma.
A salient feature of NKT cells is their ability to rapidly secrete a variety of cytokines within a short time after activation. Copious production of prototypical Th1 and Th2 cytokines, IFN- and IL-4, respectively, has been thoroughly documented. Identification of the NKT cell subsets that might specialise in Th1 versus Th2 functions has not been thoroughly investigated. The secretion of Th1 and Th2 cytokines by NKT cells is thought to underlie the regulatory properties of these cells (5, 6) , which suggests a flexible role for NKT cells in immunoregulation, although a clear difference in cytokine production between NKT cell subsets cannot be resolved at this time. Although expression profiles of Th1/Th2 cytokines between mice and humans differ, the question remains as to how these cytokines lead to a regulated immune response in vivo. The cytokine profile of NKT cells is possibly influenced by the quality of the TCR signal, which is dependent on different antigens. An -Galcer analogue with a shortened sphingosine stimulates a higher ratio of IL-4 to IFN- secretion, while a C-glycoside analogue of -Galcer promotes a higher ratio of IFN- to IL-4 (7, 8) . However, there is no structural basis for predicting how a compound will affect the cytokine profile produced by activated NKT cells.
As the first discovered human tumour virus, Epstein-Barr virus (EBV) is involved in the development of many malignancies, such as Hodgkin's lymphoma and nasopharyngeal carcinoma. EBV-induced cytotoxic T lymphocytes (CTLs) are thought to be the main effectors in cell-mediated immunity (9) . Accumulating evidence indicates that EBVinduced CTLs, including CD4 + and CD8 + T cells, are able to recognise EBV-infected cells (10) . Thus, adoptive T lymphocyte transfer following the administration of a nonmyeloablative chemotherapy regimen is proven to be an effective treatment in previous clinical trials (11) . However, the mechanism by which these CTLs respond to EBV-associated malignant tumour cells in vivo is still unknown.
In this study, we further investigated the mechanism of the EBV-induced CD8 + NKT cell response to EBV-associated malignancies based on our previous study, which demonstrated that EBV-induced CD8 + NKT cells drive syngeneic T cells into a Th1-bias response to suppress EBV-associated malignancies and that IL-4-biased CD4 + NKT cells do not affect T cell cytotoxicity. Here we found that EBV-induced CD8 + NKT cells, alone or combined with syngeneic CD4 + NKT cells, efficiently promote the Th1-bias response against Hodgkin's-derived EBV-associated B-cell lymphoma cell line (LBC)-or EBV-associated nasopharyngeal carcinoma cell line (NPC)-implanted HXTT H-T-S chimaeras. Adoptive transfer of EBV-induced cytotoxic NKT cells is a promising immunotherapy for the suppression of EBV-associated malignancies.
Materials and Methods

Patients, cells, and tetramer
Patients with Hodgkin's lymphoma were diagnosed according to the WHO criteria and staged according to the Ann Arbor classification (12) . The patients with nasopharyngeal carcinomas (NPC) were diagnosed and staged according to the International Union Against Cancer and the American Joint Committee on Cancer staging manuals (13) . Histopathology was based on the WHO international histological classification. Latent EBV-infection (LEI) or control normal subjects (CN) were healthy EBV seropositive or seronegative individuals, respectively (14) . The clinical information of all patients and subjects was listed as in our previous paper (15) . All patients were newly diagnosed and had no previous treatment. All patients and subjects provided informed consent according to institutional guidelines. Human fetal thymic cells and PBMCs were anonymously obtained from voluntarily elective pregnancy terminations (< 24-wk gestation; typing-matched HLA-A2 and HLA-DRB1(03), mismatched HLA-A11 and HLA-DQ5). The possibility of lytic and latent EBV-and HTLV-I-infections in the mothers was excluded by Q-PCR and serologic determination (16) . The fetal cells were isolated, aliquoted, cryopreserved and maintained in vapour-phase liquid nitrogen for further use. The viability of defrosted cells was evaluated by trypan blue dye exclusion before use. For transplantation, NKT cells were positively depleted from thymic cells with MACS beads in a protocol based on staining with the -GalCer-loaded CD1d tetramer (ProImmune Inc., Bradenton, FL) (17) . Human fetal peripheral CD19 + B cells (NBC), a human Hodgkin's-derived EBV-associated B-cell lymphoma cell line (L54OCY, LBC), a human nasopharyngeal epithelial cell line (NP69, NPE), a human nasopharyngeal carcinoma cell line (CNE1, NPC) and the EBV + Raji B cell line were cultured and maintained in RPMI-1640 total medium. For functional studies, NKT cells were purified from PBMCs or organs by flow cytometry cell sorting or the MACS bead system based on staining with the -GalCer-loaded CD1d tetramer (17, 18) . The -GalCerloaded CD1d tetramers were synthesised and labelled as previously described (19, 20) . All mAbs were purchased from R&D Systems Europe Ltd. (Abingdon, UK), except that the anti-V11 mAb and anti-V24 mAb were from CoulterImmunoTech (Marseille, France) and the anti-CD161 pAb was from Santa Cruz Biotechnology (Santa Cruz, CA).
Human-thymus-SCID chimaeras and humanised xenogeneic tumour-transplanted human-thymus-SCID chimaeras
To establish the human-thymus-SCID chimaeras (referred to as hu-thym-SCID chimaeras), 8-wk-old female SCID mice (NOD/LtSz-prkdc scid /prkdc scid strain, the Jackson Laboratory) were irradiated (300 cGy/mouse) prior to cell-transplantation. Human fetal thymic cells (containing 1  10 7 thymocytes, thymocytes: thymic epithelial cells and other stromal cells  1 : 1; immature and mature NKT cells were positively depleted) (17, 18) were transplanted into thymi of anaesthetised SCID mice. The chimaeras were then intrathymically challenged with EBV (10 7 pfu) (14, 21) . The challenge was repeated once after 6 days. The hu-thym-SCID chimaeras were maintained for 4 weeks (unless otherwise stated) (22) . In some cases, CD4 + or/and CD8 + NKT cells (1  10 5 cells/mouse) were purified from thymi of EBV-exposed hu-thym-SCID chimaeras (at week 4 post-establishment), mixed with syngeneic CD3 
Flow cytometry
The -GalCer-loaded CD1d tetramer was used to define total NKT cells. The appropriate isotype Abs and empty CD1d tetramer conjugated with a fluorochrome were used to gate out the NKT cells. For tetramer staining, the cells were incubated with the fluorochrome-labelled tetramer at 37°C for 15 min. For the cellular proliferation study, carboxyfluorescein diacetate succimidyl ester (CFSE) was used to label the cells, and the intensity of the CFSE fluorescence was subsequently analysed (23) . All analyses were performed with a flow cytometer (FACSCalibur, BD Biosciences). Four-color analysis was done with CellQuest software.
Real time quantitative RT-PCR
All real time quantitative RT-PCR (Q-PCR) reactions were performed as described elsewhere (24) . Briefly, total RNA from purified cells (1  10 4 , purity > 99%) or cell lines was prepared with the Quick Prep  total RNA extraction kit (Pharmacia Biotech) according to the manufacturer's instructions. RNA was reverse transcribed using oligo (dT) [12] [13] [14] [15] [16] [17] [18] and Superscript II reverse transcriptase (Life Technologies, Grand Island, USA). The real time quantitative PCR was performed in special optical tubes in a 96-well microtiter plate (Applied Biosystems, Foster City, CA) with an ABI PRISM ® 7700 Sequence Detector System (Applied Biosystems). Using the SYBR ® Green PCR Core Reagents Kit, fluorescence signals were determined for each PCR cycle via the 5' to 3' endonuclease activity of AmpliTaq Gold to provide real time quantitative PCR information. The primers and probes used in Q-PCR are listed in Table 1 .
Cytokine assays
For intracellular cytokine detection, the protocol from the Cytofix/Cytoperm Plug with Golgiplug Kit (BD PharMingen) was employed. NKT cells were exposed to various stimuli in the presence of Golgiplug and APCs at 37C for the indicated times. The cells were then intracellularly stained and subjected to flow cytometry. For ELISPOT cytokine detection, NKT cells were exposed to different stimuli in the presence of APCs, and the plates were stained with streptavidin-horseradish peroxidase (Mabtech), diluted to 1:100, and Nova Red substrate according to the manufacturers' instructions. The cytokine production of purified NKT cells was assessed by sandwich ELISA (PeproTech EC) according to the manufacturer's instructions.
Southern blots
For DNA detection in Southern blot analyses, specific TCR + NKT cell lines were generated from PBMC from latent EBV-infection subjects as described previously (25) since their high capacity to produce IFN- and IL-4. The different type 1 mDCs were purified from normal control (CN) and latent EBV-infection subjects (LEI), different patients with HL and NPC, co-cultured with CD4 + or CD8 + NKT cell lines in presence of -GalCer (1 g/ml) or -GalCer (1 g/ml) plus CD1d mAb (5 g/ml) for 24 h. The culture medium was negative control (Nil). The NKT cell lines were re-purified using MACS bead system based on staining with -GalCer-loaded CD1d tetramer after co-culture. The expressions of IFN- (left panels) and IL-4 (right panels) by CD4 + and CD8 + NKT cell lines were assessed by Q-PCR. Data were mean ± SD (n  6). *p < 0.001; **p < 0.01. (C) IFN- and IL-4 expressions in CD4 + (upper panel) and CD8 + (lower panel) NKT cell lines derived from the PBMC from different patients. The cell co-culture system was set up as described above, and stimulated in presence of -GalCer (1 g/ml) or or -GalCer (1 g/ml) plus CD1d mAb (5 g/ml) for 48 h, The culture supernatants were assessed for cytokine expression by ELISA after 48 hour-stimulatons. Data were mean ± SD (n  6). *p < 0.001. CN and LEI vs. HL and NPC; CD4 + vs. CD8 + NKT cells. Table 1 . DNA (5 g) was electrophoresed under denaturing conditions, followed by transfer onto a nylon membrane. The membrane was then hybridised overnight with 1  10 6 cpm/ml of 32 P-labelled probe, followed by autoradiography.
Statistical analysis
Statistical analyses were performed using paired or unpaired Student's t test. A p value < 0.05 was considered statistically significant.
Results
Circulating mDC1 cells from patients with EBV-associated malignancies impaired IFN- production of CD8
+ NKT cells In our previous study, we found that the frequencies of total and CD8 + NKT cells in PBMCs from LEI and CN subjects were significantly higher than those from HL and NPC patients. Cytotoxic assays demonstrated that CD8 + NKT cells from LEI subjects strongly targeted -GalCer-loaded HL and NPC cell lines, resulting in a high level of cell death, while CD4 + NKT cells from various subjects either lacked or showed very weak cytotoxicity to both -GalCer-loaded tumour cell lines and non-tumour cells (15) . To understand the relationship between NKT cells and APCs, we examined circulating DCs from patients with EBV-associated malignancies and healthy subjects. The frequencies of mDC1 cells were comparable among HL and NPC patients and LEI and CN subjects. Furthermore, we determined the expression profile of CD1d and found that CD1d was predominantly expressed on mDC1 cells compared with mDC2 cells and pDC cells. The expression levels of CD1d on mDC1 cells were comparable among HL and NPC patients and LEI and CN subjects ( Figure 1A ). Due to the high capacity of NKT cells to produce IFN- and IL-4, these cytokines were detected in both CD4
+ and CD8 + NKT cell lines from PBMCs derived from various EBV-infection subjects. Coexisting with circulating DCs, CD4
+ and CD8 + NKT cells from LEI and CN subjects highly expressed IFN- upon pre-stimulation with -GalCer, while IL-4 levels were approximately equal in the various subjects ( Figure 1B ). The levels of cytokines produced by purified NKT cells were confirmed by means of an ELISA assay. After stimulation with -GalCer alone, expression levels of IFN- were significantly higher in CD8 + (lower panel) NKT cell lines derived from the PBMCs from CN and LEI subjects than patients, while the IL-4 levels were generally high in CD4 + (upper panel) NKT cells derived from the PBMCs from both patients with HL and NPC and CN and LEI subjects ( Figure  1C ). Circulating mDC1 cells from HL or NPC patients impaired IFN- production by CD8 + NKT cell lines, but did not affect IL-4 production ( Figure 1B ), in agreement with a previous observation (25) .
EBV-induced CD8
+ NKT cells promote a Th1-bias response that suppresses EBV-associated tumour cells in vitro We previously found that the frequencies of total and CD8 + NKT cells in PBMCs from HL and NPC patients (< 3%) were significantly lower than those from LEI and CN subjects (15-30%). By contrast, the frequency of CD4 + NKT cells was comparable among various patients and subjects, as was the frequency of CD4 -CD8 -(DN) NKT cells, although this frequency was low in all groups (15) . CD4 + NKT cells in PBMCs of HL and NPC patients and LEI and CN controls produced similar low levels of IFN- and high levels of IL-4, IL-13, IL-10 and TGF-1. CD8 + NKT cells from LEI and CN subjects expressed very high levels of IFN- and IL-2, but low levels of IL-4, IL-13, IL-10, and TGF-1. CD8 + NKT cells from HL and NPC patients produced much less IFN- than cells from the control subjects. CD8 + NKT cells from LEI and CN subjects efficiently killed -GalCer-loaded EBV-associated HL and NPC cell lines, but not non-tumour cells, while CD8 + NKT cells from HL and NPC patients displayed only moderate cytotoxicity against these -GalCer-loaded EBV-associated cell lines. CD8 + NKT cells The HXTT H-T-S chimeras were implanted with LBC (A) or NPC (B) as described in Methods. The NKT cells from the unchallenged hu-thym-SCID chimera were used as a control (data not shown). The animals were euthanized at week 12 post-tumor-implantation. The various organs as indicated were collected and single cell suspensions were prepared. pBlood, peripheral blood. The cells were in vitro stimulated with -GalCer (1 g/ml) for 12h. The indicated cytokines in NKT cells were examined by tetra-color (cytokine Ab, CD4 Ab, CD8 Ab, CD1d tetramer) intracellular flow cytometry. An experimental and analysis schemes were illustrated in the leftmost panel. Data were mean ± SD (n  5). * p < 0.001. from LEI subjects strongly targeted -GalCer-loaded HL and NPC cell lines, resulting in a high level of cell death. CD4 + NKT cells from various patients and subjects lacked or showed very weak cytotoxicity to both -GalCer-loaded tumour cell lines and non-tumour cells (15) .
In our previous study, we also found that EBV-induced human NKT cells rapidly responded to EBV-associated tumour cells through the secretion of cytotoxic cytokines, such as IFN- and IL-10 (15). In order to verify the specificity of the cytotoxic killing of the target cells, we first demonstrated the existence of EBV in different cell lines. Five transformation-associated EBV-genes including LMP1, EBNA1, BZLFl, BALF2 and RAZ were examined in human EBV-associated tumour cell lines and non-tumour cell lines. Using Southern blot and Q-PCR analysis, these viral genes and their mRNA transcripts were detected in EBV-associated tumour cell lines (L54OCY and CNE1), but not in non-tumour cells (fetal CD19
+ B cells and a nasopharyngeal epithelial cell line NP69) (Figure 2) .
To elucidate the mechanism by which NKT cells inhibit EBV-associated malignancies in vivo, we established huthym-SCID chimaeras (22) . Our cytotoxicity assay demonstrated that CD8 + NKT cells from various organs of EBV-exposed hu-thym-SCID chimaeras displayed a strong proliferative capacity and cytotoxicity against -GalCerprimed EBV-associated tumour cell lines in vitro. Transferred thymic CD8 + NKT cells (plus spleen syngeneic T cells and DCs, referred to as +T+DC) from EBV-exposed hu-thym-SCID chimaeras efficiently functioned as protective effectors against human EBV-associated HL and NPC (15) . We next examined the cytokine production of NKT cells ex vivo in HXTT H-T-S chimaeras transferred with EBV-induced CD4 3B ; some data not shown). The differential cytokine production patterns of CD4 + and CD8 + NKT cells were confirmed by Q-PCR (data not shown).
EBV-induced CD4
+ NKT cells synergised with CD8 + NKT cells to promote a Th1-bias response against EBVassociated tumours In our previous study, we established several virus-exposed hu-thym-SCID chimaeras and demonstrated for the first time that EBV promotes the generation of IFN--biased CD8 + NKT cells in human-thymus-SCID chimaeras. Thymic CD8 + NKT cells from EBV-exposed hu-thym-SCID chimaeras promoted Th1 immunity, but CD4 + NKT cells displayed a Th2-bias response (15) . The synergistic effect of EBVexposed thymic CD4 + and CD8 + NKT cells significantly suppressed EBV-associated malignancies and prolonging animal survival (15) . In a semi-permeable transwell membrane co-culture system, which prevented direct cell-cell contact between syngeneic spleen CD3 + CD56 -CD161 -T cells and NKT cells (24) , the NKT cells lost their ability to direct biased cytokine secretion by syngeneic T cells (data not shown), strongly suggesting that this NKT cell activity is cell-cell contact dependent.
To further investigate the mechanism of the synergistic effect between EBV-exposed CD4 + and CD8 + NKT cells in suppressing EBV-associated malignancies, we established EBV-sensitised chimaeras (non-tumour-bearing model) by transfer with EBV-exposed CD4 + or/and CD8 + NKT cells plus syngeneic CD3
-T cells, and re-challenged them with EBV. Both CD4 + and CD8 + NKT cells showed comparable levels of proliferation in various chimaeras in response to the EBV re-challenge ( Figure 4A ). CD4 + NKT cells mainly produced IL-4, and a high frequency of CD8 + NKT cells expressed IFN- in response to EBV re-challenge ( Figure 4B ). In the chimaeras transferred with EBV-exposed CD4 + NKT cells alone, the proliferation of CD3 + T cells was inhibited following the EBV re-challenge, compared with that for chimaeras transferred with EBV-exposed CD8 + NKT cells alone ( Figure 4C ). The CD3 + T cells predominantly produced IL-4 in the chimaeras transferred with EBVexposed CD4 + NKT cells alone, while the T cells expressed a high level of IFN- in the chimaeras transferred with EBV-exposed CD8 + NKT cells alone ( Figure 4D ). Vigorous proliferation of CD3 + T cells and a high frequency of IFN- producing cells were observed in the chimaeras transferred with EBV-exposed CD4 + and CD8 + NKT cells together, in response to EBV re-challenge ( Figure 4C, 4D) . + and CD8 + NKT cells. In this experiment, the purified thymic CD4 + or CD8 + NKT cells from EBV-exposed chimeras were labelled with CFSE prior to the transfer into the SCID mice. After EBV re-challenge, EBV-sensitized chimeras were euthanized. The PBMC were stained with appropriate tetramer/ Abs, and analyzed by flow cytometry. ND, no determination. Data were representative (n  6). (B) IFN- and IL-4 expression by CD4 + and CD8 + NKT cells. As described above, EBVsensitized chimeras were euthanized after EBV re-challenge. The indicated cytokines in NKT cells were examined by tetra-color (cytokine Ab, CD4 Ab, CD8 Ab, CD1d tetramer) intracellular flow cytometry. The experimental and analysis schemes were illustrated in the leftmost panel of Figure 3 (without tumor-implantation). ND, no determination. Data were mean ± SD (n  5). *p < 0.001. (C) Proliferation of EBV-specific CD3 + CD56 -CD161 -T cells. The EBVsensitized chimeras were established as described above. The purified spleen CD3 +
CD56
-CD161 -T cells were labelled with CFSE prior to transfer into the SCID mice. The EBV-sensitized chimeras were euthanized after EBV re-challenges, and PBMC were stained with appropriate tetramer/Abs, then analyzed by flow cytometry for cell proliferation. Data were mean ± SD (n  5). *p < 0.001. (D) IFN- and IL-4 expression by CD3 + T cells. Analysis was performed as described above. The indicated cytokines in CD3 + T cells were examined by intracellular flow cytometry. Data were mean ± SD (n  5). *p < 0.001. An effective cancer immunosurveillance process associated with CD8 + NKT cells exists in subjects with latent EBV infection, but without pathogenesis, due to different frequencies of CD8 + NKT cells in different subjects. Various cytokines and cell populations are also involved in the cancer immunosurveillance process. IFN--deficient mice exhibited an increased incidence of carcinoma, suggesting that IFN--dependent immune responses might be effective in the promotion phase of carcinogenesis (27) . IFN- and IL-4 are typical Th1 and Th2 related cytokines, respectively. These two cytokines can be used to evaluate Th1/Th2 differentiation. Previous studies showed that activated NKT cells regulate immune responses, including tumour rejection, by producing IFN- and IL-4 (28) . NKT activation after -GalCer treatment can alter the balance of secreted cytokines from a Th2-bias to a Th1-bias (29) . Similarly, our data demonstrated that EBV-induced CD8 + NKT cells promoted a Th1-bias response to suppress EBV-associated tumour cells in vivo.
IFN- is an essential cytokine in the viral cell-mediated immune response. IFN- production is a sensitive indicator of target cell recognition by responsive lymphocytes that are reactive to virus-associated antigens. Antitumor responses and responses to infectious agents depend on IFN- secreted by NKT cells, but NKT cells are not the sole, or even the major, source of responsive cytokines. Therefore, activation of NKT cells results in a responsive activation cascade. The synergistic antitumor effect of EBV-exposed CD4 + and CD8 + NKT cells is quite impressive in this study because the combined transfer of EBV-induced CD4 + and CD8 + NKT cells leads to a significant proliferation of CD4 + and CD8 + NKT cells and higher production of IFN-. We have observed that EBV-induced CD8 + NKT cells are necessary and sufficient to enhance T cell immunity to suppress EBVassociated malignancies in human-thymus-SCID chimaeras (15) . The necessary outcome is an increased Th1-bias response to EBV-associated malignancies when EBVexposed CD4
+ NKT cells cooperated with CD8 + NKT cells in LBC-or NPC-bearing HXTT H-T-S chimaeras. The EBVexposed CD4 + NKT cells that are centrally important for persistence of CD8 + NKT in vivo exert a synergistic effect to suppress EBV-induced malignancies. Activation of NKT cells also affects nearly every hematopoietic cell type, including DCs, NK cells, B lymphocytes, and T lymphocytes. As reported, NK cells are stimulated to secrete IFN- within a few hours after -GalCer stimulation (30) . The intensity of the immune response of a particular glycolipid may depend on how much it stimulates communication between NKT cells and other cell types. Therefore, EBV exposure is a major contributor to Th1-biased immunity in this study. However, the identity of these viral antigens and the mechanism in which they affect the pattern of cytokines and immune responses in vivo must be further investigated. In addition, the integration of weak TCR signals and IL-12R-mediated signals may lead to a Th1-biased cytokine production by NKT cells (18) . The cytokine profile of activated NKT cells can be influenced by the generation of signals from various types of receptors. Other cellular signals may contribute to Th1-biased cytokine profiles produced by EBV-induced CD8 + NKT cells alone or together with synergistic EBV-induced CD4 + NKT cells. Adoptive transfer of donor-derived EBV-induced CTLs has been successful in the prevention and treatment of EBV-associated post-transplant lymphoproliferative disorders (PTLDs) in the context of allogeneic stem cell transplantation (31) . Therefore, the adoptive transfer of EBV-induced CD8 + NKT cells alone or combined with syngeneic EBV-induced CD4 + NKT cells is a promising immunotherapy for the suppression of EBV-associated malignancies.
